CD34 and Hodgkins lymphoma: Clinically, Romano et al. (2015) reported an increase in M-MDSCs, PMN-MDSCs and CD34+ MDSCs in peripheral blood of Hodgkin’s lymphoma (HL) patients as compared to healthy individuals.